Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Plos One|January 4, 2014
Genetic heterogeneity of susceptibility gene in different ethnic populations: refining association study of PTPN22 for Graves' disease in a Chinese Han populationLiqiong Xue, Chunming Pan, Zhaohui Gu, et al.
Blood Cancer Discovery|March 5, 2022
ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute LeukemiaKirsten M Dickerson, Chunxu Qu, Qingsong Gao, et al.
Communications Biology|March 21, 2023
Isoform-specific knockdown of long and intermediate prolactin receptors interferes with evolution of B-cell neoplasmsAdeleh Taghi Khani, Anil Kumar, Ashly Sanchez Ortiz, et al.
Blood|September 4, 2020
Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALLYaqi Zhao, Ibrahim Aldoss, Chunxu Qu, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Knockdown of the long isoform of the prolactin receptor selectively targets pathogenic immune cells in systemic lupus erythematosus and averts glomerular pathologyKory Hamane, Zunsong Hu, Joao Rodrigues Lima-Junior, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2019
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALLKathryn Evans, JianXin Duan, Tara Pritchard, et al.
Blood Cancer Discovery|July 12, 2021
Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapySima Jeha, John Choi, Kathryn G Roberts, et al.
Blood|August 23, 2021
The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13Costanza Zanetti, Rahul Kumar, Joscha Ender, et al.
American Journal of Hematology|July 23, 2026
Clinical Implications of CD19-Negative Relapse Following CD19-Directed Therapy in B-Cell Acute Lymphoblastic LeukemiaTamer Othman, Vaibhav Agrawal, Joo Y Song, et al.
Journal for Immunotherapy of Cancer|May 22, 2023
Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemiaAnil Kumar, Adeleh Taghi Khani, Caroline Duault, et al.
Pageof 6